Lv41
550 积分 2026-05-11 加入
202eP Impact of TP53 co-mutations on progression-free survival in EGFR-mutant NSCLC: A real-world analysis from a tertiary care center in central India
58分钟前
求助中
Comments on: “Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy”
2个月前
已关闭
Safety and Efficacy of Osimertinib in Patients With Non–Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis
2个月前
已完结
Current treatment landscape for patients with non–small cell lung cancer with common EGFR mutations
2个月前
已完结
Role of EGFR-TKIs in Nonmetastatic Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Comprehensive Review
2个月前
已完结
皖公网安备34019202002308
